These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25209366)

  • 1. Evaluation of near infrared fluorescent labeling of monoclonal antibodies as a tool for tissue distribution.
    Conner KP; Rock BM; Kwon GK; Balthasar JP; Abuqayyas L; Wienkers LC; Rock DA
    Drug Metab Dispos; 2014 Nov; 42(11):1906-13. PubMed ID: 25209366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates.
    Sato K; Nagaya T; Nakamura Y; Harada T; Nani RR; Shaum JB; Gorka AP; Kim I; Paik CH; Choyke PL; Schnermann MJ; Kobayashi H
    Mol Pharm; 2015 Sep; 12(9):3303-11. PubMed ID: 26261913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of knockout mouse models to investigate the influence of FcγR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibody.
    Abuqayyas L; Balthasar JP
    Int J Pharm; 2012 Dec; 439(1-2):8-16. PubMed ID: 23018115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice.
    Yang Y; Li TR; Balthasar JP
    AAPS J; 2017 Nov; 19(6):1791-1803. PubMed ID: 28849396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice.
    Shah DK; Balthasar JP
    Int J Pharm; 2014 Apr; 465(1-2):228-38. PubMed ID: 24508555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition.
    Bordeau BM; Polli JR; Schweser F; Grimm HP; Richter WF; Balthasar JP
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
    Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.
    Shah DK; Betts AM
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):67-86. PubMed ID: 22143261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the influence of nephropathy on monoclonal antibody disposition: a pharmacokinetic study in a mouse model of diabetic nephropathy.
    Engler FA; Zheng B; Balthasar JP
    Pharm Res; 2014 May; 31(5):1185-93. PubMed ID: 24203494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer.
    Abuqayyas L; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):683-710. PubMed ID: 23184417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.
    Ghosh SC; Rodriguez M; Carmon KS; Voss J; Wilganowski NL; Schonbrunn A; Azhdarinia A
    J Nucl Med; 2017 Nov; 58(11):1858-1864. PubMed ID: 28572490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
    Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
    Ann Surg Oncol; 2024 Sep; 31(9):6291-6299. PubMed ID: 38888861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.
    Cilliers C; Nessler I; Christodolu N; Thurber GM
    Mol Pharm; 2017 May; 14(5):1623-1633. PubMed ID: 28294622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.
    Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
    Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach.
    Betts A; Keunecke A; van Steeg TJ; van der Graaf PH; Avery LB; Jones H; Berkhout J
    MAbs; 2018 Jul; 10(5):751-764. PubMed ID: 29634430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies.
    Cao Y; Balthasar JP; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2013 Oct; 40(5):597-607. PubMed ID: 23996115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies.
    Avery LB; Wang M; Kavosi MS; Joyce A; Kurz JC; Fan YY; Dowty ME; Zhang M; Zhang Y; Cheng A; Hua F; Jones HM; Neubert H; Polzer RJ; O'Hara DM
    MAbs; 2016; 8(6):1064-78. PubMed ID: 27232760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the role of FcγR and FcRn in mAb distribution to the brain.
    Abuqayyas L; Balthasar JP
    Mol Pharm; 2013 May; 10(5):1505-13. PubMed ID: 22838637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab
    Polikarpov DM; Campbell DH; McRobb LS; Wu J; Lund ME; Lu Y; Deyev SM; Davidson AS; Walsh BJ; Zvyagin AV; Gillatt DA
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32316186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.